AU4825200A - Oral steroidal hormone compositions and methods of use - Google Patents

Oral steroidal hormone compositions and methods of use

Info

Publication number
AU4825200A
AU4825200A AU48252/00A AU4825200A AU4825200A AU 4825200 A AU4825200 A AU 4825200A AU 48252/00 A AU48252/00 A AU 48252/00A AU 4825200 A AU4825200 A AU 4825200A AU 4825200 A AU4825200 A AU 4825200A
Authority
AU
Australia
Prior art keywords
methods
steroidal hormone
hormone compositions
oral
oral steroidal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU48252/00A
Inventor
Vassem Ali
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Texas System
Original Assignee
University of Texas System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Texas System filed Critical University of Texas System
Publication of AU4825200A publication Critical patent/AU4825200A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63Steroids; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
AU48252/00A 1999-05-07 2000-05-05 Oral steroidal hormone compositions and methods of use Abandoned AU4825200A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13308599P 1999-05-07 1999-05-07
US60133085 1999-05-07
PCT/US2000/012404 WO2000067708A2 (en) 1999-05-07 2000-05-05 Oral steroidal hormone compositions and methods of use

Publications (1)

Publication Number Publication Date
AU4825200A true AU4825200A (en) 2000-11-21

Family

ID=22456942

Family Applications (1)

Application Number Title Priority Date Filing Date
AU48252/00A Abandoned AU4825200A (en) 1999-05-07 2000-05-05 Oral steroidal hormone compositions and methods of use

Country Status (2)

Country Link
AU (1) AU4825200A (en)
WO (1) WO2000067708A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
CA2426521A1 (en) * 2000-11-17 2002-05-23 Warner-Lambert Company Llc Treatment of sexual dysfunction using bombesin antagonist
IL158871A0 (en) 2001-07-31 2004-05-12 Pfizer Prod Inc Pharmaceutical compositions, kits and methods comprising combinations of estrogen agonists/antagonists, estrogens and progestins
US20220339176A1 (en) * 2019-09-23 2022-10-27 The Board Of Trustees Of The Leland Stanford Junior University Methods of Treatments to Prolong Gestation and Complications of Menstruation or Gestation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU532512B2 (en) * 1979-09-07 1983-10-06 Upjohn and Horton Anti-allergenic compounds for bone mineral resorption
US4963346A (en) * 1988-05-31 1990-10-16 Amer & Company, Inc. Method and composition for treatment or prevention of dental plaque calculus and gingivitis
US5262164A (en) * 1989-11-17 1993-11-16 The Procter & Gamble Company Sustained release compositions for treating periodontal disease
US5013728A (en) * 1990-05-04 1991-05-07 Colgate - Palmolive Company Composition for treating osteoporosis and hormonal imbalance
US5310545A (en) * 1991-04-11 1994-05-10 Drore Eisen Method of treatment using mouthwashes containing steroids and antifungal agents and compositions of matter
WO1994016673A1 (en) * 1993-01-19 1994-08-04 The Gillette Company Mouthrinse
US5939047A (en) * 1996-04-16 1999-08-17 Jernberg; Gary R. Local delivery of chemotherapeutic agents for treatment of periodontal disease
DE19832169A1 (en) * 1998-07-17 2000-01-27 Jenapharm Gmbh Treating or preventing oral atrophic symptoms, e.g. marginal periodontal disease, by local administration of estrogen such as estriol

Also Published As

Publication number Publication date
WO2000067708A3 (en) 2001-02-08
WO2000067708A2 (en) 2000-11-16

Similar Documents

Publication Publication Date Title
AU4300701A (en) Methods and compositions for administration of therapeutic reagents
HK1048247A1 (en) Stable carotene-xanthophyll beadlet compositions and methods of use
EP1227821A4 (en) Therapeutic compositions and methods of use thereof
AU2609901A (en) Antimicrobial compositions and methods of use
AU7362301A (en) Bioadhesive compositions and methods of preparation and use
AU2001234437A1 (en) Deicing compositions and methods of use
AU3887900A (en) Protamine fragment compositions and methods of use
HUP0201872A2 (en) Steroid compounds and pharmaceutical compositions of the same
AU7907300A (en) Novel combination of loteprednol and antihistamines
AU5326100A (en) Pharmaceutical compositions and methods for use
AU4134101A (en) Hormone receptor functional entities and methods of their use
AU1460801A (en) Cholesterol reducing sterol compositions, preparation and method of use
WO2001041823A8 (en) Radioactive compositions and methods of use thereof
AUPP968699A0 (en) Therapeutic compositions and method for their preparation
AU5565099A (en) Pharmaceutical compositions and methods for use
AU2002216346A1 (en) Cabergoline pharmaceutical compositions and methods of use thereof
AP2001002371A0 (en) Streptogramin derivatives preparation and compositions containing them
AU2002217841A1 (en) Neuroactive steroid derivatives and methods of use
IL143776A0 (en) Clathrates of dehydroepiandrosterone and corresponding pharmaceutical compositions
AU2001287198A1 (en) Dental restorative compositions and method of use thereof
AU1152601A (en) Compositions and their use
AU2962400A (en) Cleaner composition and method of use thereof
AU4825200A (en) Oral steroidal hormone compositions and methods of use
AU4839100A (en) Methods of using and compositions comprising n-desmethylzolpidem
AU2738000A (en) Oral hygiene preparations; associated methods and kit

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase